CANCER GENET-NY - Cancer Genetics and Cytogenetics - Cancer Genetics

Publications

  1. 2015
  2. Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer

    Ghadban, T., Schmidt-Yang, M., Uzunoglu, F. G., Perez, D. R., El Gammal, A. T., Miro, J. T., Wellner, U., Pantel, K., Izbicki, J. R. & Vashist, Y. K., 09.10.2015, In: CANCER GENET-NY. 208, 12, p. 595–601

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2014
  4. Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB)

    Bartelheim, K., Sumerauer, D., Behrends, U., Kodetova, D., Kucera, F., Leuschner, I., Neumayer, P., Oyen, F., Rübe, C., Siebert, R., Schneppenheim, R., Seeringer, A., Vasovcak, P. & Frühwald, M. C., 01.09.2014, In: CANCER GENET-NY. 207, 9, p. 379-83 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells

    Vu-Han, T-L., Frühwald, M. C., Hasselblatt, M., Kerl, K., Nagel, I., Obser, T., Oyen, F., Siebert, R. & Schneppenheim, R., 01.09.2014, In: CANCER GENET-NY. 207, 9, p. 390-397 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor

    Seeringer, A., Reinhard, H., Hasselblatt, M., Schneppenheim, R., Siebert, R., Bartelheim, K., Leuschner, I. & Frühwald, M. C., 01.09.2014, In: CANCER GENET-NY. 207, 9, p. 429-33 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Reduced membranous MET expression is linked to bladder cancer progression

    Kluth, M., Reynolds, K., Rink, M., Chun, F., Dahlem, R., Fisch, M., Höppner, W., Wagner, W., Doh, O., Terracciano, L., Simon, R., Sauter, G. & Minner, S., 01.04.2014, In: CANCER GENET-NY. 207, 4, p. 147-52 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. 2010
  9. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.

    Bacher, U., Haferlach, T., Kern, W., Alpermann, T., Schnittger, S. & Haferlach, C., 2010, In: CANCER GENET-NY. 203, 2, p. 169-175 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia.

    Bacher, U., Haferlach, T., Schnittger, S., Weiss, T., Burkhard, O., Bechtel, B., Kern, W. & Haferlach, C., 2010, In: CANCER GENET-NY. 200, 2, p. 170-174 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. 2009
  12. Amplification and expression of EGFR and ERBB2 in Wilms tumor.

    Vasei, M., Helmout, M., Ale-Booyeh, O., Mosallaei, A., Kajbafzadeh, A. M., Shahriari, M., Ghaderi, A. A., Soleymanpour, H., Kosari, F., Moch, H. & Sauter, G., 2009, In: CANCER GENET-NY. 194, 2, p. 88-95 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.

    Schafhausen, P., Dierlamm, J., Bokemeyer, C., Brümmendorf, T., Bacher, U., Zander, A. R., Schnittger, S. & Hochhaus, A., 2009, In: CANCER GENET-NY. 189, 1, p. 63-67 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.

    Bug, S., Dürig, J., Oyen, F., Klein-Hitpass, L., Martin-Subero, J. I., Harder, L., Baudis, M., Arnold, N., Kordes, U., Dührsen, U., Schneppenheim, R. & Siebert, R., 2009, In: CANCER GENET-NY. 192, 1, p. 44-47 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. 2008
  16. A closer look at Warthin tumors and the t(11;19).

    Fehr, A., Röser, K., Belge, G., Löning, T. & Bullerdiek, J., 2008, In: CANCER GENET-NY. 180, 2, p. 135-139 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.

    Haferlach, C., Bacher, U., Tiu, R., Maciejewski, J. P. & List, A., 2008, In: CANCER GENET-NY. 187, 2, p. 101-111 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. 2007
  19. A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia.

    Bacher, U., Haferlach, T., Kern, W., Harich, H-D., Schnittger, S. & Haferlach, C., 2007, In: CANCER GENET-NY. 175, 1, p. 52-56 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. A new interphase fluorescence in situ hybridization approach for genomic rearrangements involving MLH1 and MSH6 in hereditary nonpolyposis colorectal cancer-suspected mutation-negative patients.

    Koehler, U., Grabowski, M., Bacher, U. & Holinski-Feder, E., 2007, In: CANCER GENET-NY. 175, 1, p. 81-84 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. 2006
  22. Frequency of chromosomal aneuploidies and deletions of the RB and TP53 genes in MALT lymphomas harboring the t(14;18)(q32;q21).

    Murga-Penas, E-M., Hinz, K., Biller, L., Zivkovic, T., Röser, K., Löning, T., Parwaresch, R., Bokemeyer, C. & Dierlamm, J., 2006, In: CANCER GENET-NY. 164, 1, p. 81-83 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. 2004
  24. Dicentric (19;21)(p13;p13), a novel chromosomal abnormality occurring in a case of Philadelphia chromosome-positive acute lymphoblastic leukemia.

    Schilling, G., Dierlamm, J., Murga-Penas, E-M., Hinz, K., Seeger, D. & Hossfeld, D. K., 2004, In: CANCER GENET-NY. 152, 2, p. 129-131 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. 2003
  26. Deletion of chromosome 15 represents a rare but recurrent chromosomal abnormality in myelocytic malignancies.

    Dierlamm, J., Schilling, G., Michaux, L., Hinz, K., Murga-Penas, E-M., Seeger, D., Hagemeijer, A. & Hossfeld, D. K., 2003, In: CANCER GENET-NY. 144, 1, p. 1-5 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. 2001
  28. Chromosomal gains and losses are uncommon in hairy cell leukemia: a study based on comparative genomic hybridization and interphase fluorescence in situ hybridization.

    Dierlamm, J., Stefanova, M., Wlodarska, I., Michaux, L., Hinz, K., Murga-Penas, E-M., Maes, B., Hagemeijer, A., De Wolf-Peeters, C. & Hossfeld, D. K., 2001, In: CANCER GENET-NY. 128, 2, p. 164-167 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. 1999
  30. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas

    Kluwe, L., Friedrich, R. E. & Mautner, V. F., 01.08.1999, In: CANCER GENET-NY. 113, 1, p. 65-9 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.

    Lamszus, K., Kluwe, L., Matschke, J., Meissner, H., Laas, R. & Westphal, M., 1999, In: CANCER GENET-NY. 110, 2, p. 103-110 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. 1996
  33. MLL/ENL fusion in congenital acute lymphoblastic leukemia with a unique t(11;18;19).

    Horstmann, M., Argyriou-Tirita, A., Borkhardt, A., Kabisch, H., Kapaun, P., Winkler, K. & Haas, O. A., 1996, In: CANCER GENET-NY. 88, 2, p. 103-109 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. 1993
  35. An ovarian thecoma with a single numerical aberration: +12.

    Walter, T. A., Rieck, J., Hossfeld, D. K. & Löning, T., 1993, In: CANCER GENET-NY. 71, 2, p. 180-182 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review